Atopic dermatitis (AD) presents differently among diverse patient populations which may affect its evaluation and treatment. In individuals with darker skin-phenotypes, the increased melanin pigment might impact the visibility of erythema, leading to a misclassification of AD severity. Current education on assessing AD in clinical trials and practice tends to be biased towards patients with lighter skin-phenotypes. Researchers hypothesized that clinician-reported outcome measures (ClinROMs) may not be as effective in assessing AD in patients with skin of color compared to those with lighter skin-phenotypes. This was investigated through a prospective study in both children and adults with AD to determine if ClinROMs show weaker correlations with established patient-reported outcome measures across different races or ethnicities.
Read more at the Journal of the American Academy of Dermatology.